Takeda (ADR) (TAK)
Develops prescription medicines across gastrointestinal disease, rare disease, plasma therapies, oncology, neuroscience, and vaccines.
$19.02
vs last close+0.13 (+0.66%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 3.30% | 104.85M ADS | |
|---|---|---|---|
| 387 holders · as of Jun 30, 2026 | |||
| Insiders | 0.09% | 2.75M ADS | |
| 14 holders · as of Sep 15, 2026 | |||
| Other | 96.61% | 3.07B ADS | |
| remainder | |||
3.18B ADS as of Sep 20, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
The share count has not been confirmed by a second filing; stakes use it as it stands.
Some positions are filed in underlying shares, not receipts; the ratio is unknown, so no percentage.
13F, as of Jun 30, 2026
387 holders · 104.85M shares · 70 new positions · 212 increased · 102 reduced · 51 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Capital Research Global Investors | 19.30M | 0.61% | +193.5K | Aug 12, 2026 |
| FMR LLC | 9.60M | 0.30% | +2.48M | Aug 13, 2026 |
| Morgan Stanley | 6.99M | 0.22% | +525.3K | Aug 13, 2026 |
| Adage Capital Partners GP, L.L.C. | 6.05M | 0.19% | −374.2K | Aug 14, 2026 |
| Goldman Sachs Group Inc | 5.13M | 0.16% | −493.7K | Aug 14, 2026 |
| Brandes Investment Partners, LP | 4.54M | 0.14% | +108.7K | Aug 14, 2026 |
| Arrowstreet Capital, Limited Partnership | 3.73M | 0.12% | +616.6K | Aug 13, 2026 |
| BlackRock, Inc. | 3.69M | 0.12% | +511.7K | Aug 7, 2026 |
13D/G · 5% or more, as filed
No 13D/G filer at 5% or more on record.
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Sep 14, 2026 | Lauren Rusckowski Dupreyofficer: Chief Transformation Officer | Sale | 34,535 | $18.54 | 191,522 |
| Sep 2, 2026 | Andrew Stewart Plumpdirector, officer: President, R&D | Sale | 116,191 | $18.49 | 145,465 |
| Aug 19, 2026 | Andrew Stewart Plumpdirector, officer: President, R&D | Sale | 19,651 | $18.49 | 261,656 |
| Aug 18, 2026 | Nicola Deidre Petal Greenwayofficer: Chief Human Resources Officer | Sale | 12,980 | $18.11 | 40,049 |
| Aug 10, 2026 | Rhonda Janice Pachecoofficer: President, U.S. Business Unit | Sale | 16,901 | $17.10 | 182,507 |
| Aug 10, 2026 | Ramy Riad Ahmed Ibrahimofficer: President, PDT BU | Sale | 7,277 | $17.10 | 102,588 |
| Aug 10, 2026 | Awny Samaan Botros Farajallahofficer: Chief Medical Officer | Sale | 14,006 | $17.10 | 116,177 |
| Aug 10, 2026 | Andrew Stewart Plumpdirector, officer: President, R&D | Sale | 165,393 | $17.10 | 766,569 |
| Aug 10, 2026 | Lauren Rusckowski Dupreyofficer: Chief Transformation Officer | Sale | 47,586 | $17.10 | 226,057 |
| Aug 10, 2026 | Teresa Marie Bitettiofficer: President, OBU | Sale | 50,012 | $17.10 | 252,010 |
House and Senate disclosures
Not reported.